Print page content Print
Increase text size Decrease text size
Text Size

VANGUARD® Rapid Resp 2 Intranasal

Canine Infectious Respiratory Disease (CIRD) Background

Infectious respiratory disease in the dog is multifactorial, both bacterial and viral pathogens are frequently observed.  The clinical signs will often be identical regardless of the infecting pathogen.  Additionally, when respiratory diagnostic testing is performed in symptomatic dogs co-infections are often observed.  The presence of multiple pathogens may lead to more severe symptoms.   A multivalent immunization protocol can help PREVENT THE PREVENTABLE.

Collapse All
    • Vanguard Rapid Resp 2 Intranasal helps protect dogs from two key pathogens associated with CIRD
    • Single-nostril (0.5 mL) respiratory vaccine that helps make administration fast and comfortable
    • Intranasal administration via syringe
  • For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing canine parainfluenza caused by canine parainfluenza virus (CPiV) and disease caused by Bordetella bronchiseptica.

    Also available in trivalent (Bb, CPiV, CAV-2) and monovalent (Bb) options.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2021 Zoetis Services LLC. All rights reserved.